Literature DB >> 33670336

The Effect of Octapeptide Repeats on Prion Folding and Misfolding.

Kun-Hua Yu1, Mei-Yu Huang1, Yi-Ru Lee1, Yu-Kie Lin1, Hau-Ren Chen1, Cheng-I Lee1.   

Abstract

Misfolding of prion protein (PrP) into amyloid aggregates is the central feature of prion diseases. PrP has an amyloidogenic C-terminal domain with three α-helices and a flexible tail in the N-terminal domain in which multiple octapeptide repeats are present in most mammals. The role of the octapeptides in prion diseases has previously been underestimated because the octapeptides are not located in the amyloidogenic domain. Correlation between the number of octapeptide repeats and age of onset suggests the critical role of octapeptide repeats in prion diseases. In this study, we have investigated four PrP variants without any octapeptides and with 1, 5 and 8 octapeptide repeats. From the comparison of the protein structure and the thermal stability of these proteins, as well as the characterization of amyloids converted from these PrP variants, we found that octapeptide repeats affect both folding and misfolding of PrP creating amyloid fibrils with distinct structures. Deletion of octapeptides forms fewer twisted fibrils and weakens the cytotoxicity. Insertion of octapeptides enhances the formation of typical silk-like fibrils but it does not increase the cytotoxicity. There might be some threshold effect and increasing the number of peptides beyond a certain limit has no further effect on the cell viability, though the reasons are unclear at this stage. Overall, the results of this study elucidate the molecular mechanism of octapeptides at the onset of prion diseases.

Entities:  

Keywords:  fibril; folding; misfolding; octapeptide; prion

Mesh:

Substances:

Year:  2021        PMID: 33670336      PMCID: PMC7918816          DOI: 10.3390/ijms22041800

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  39 in total

1.  Octapeptide repeat insertions in the prion protein gene and early onset dementia.

Authors:  E A Croes; J Theuns; J J Houwing-Duistermaat; B Dermaut; K Sleegers; G Roks; M Van den Broeck; B van Harten; J C van Swieten; M Cruts; C Van Broeckhoven; C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

2.  The same primary structure of the prion protein yields two distinct self-propagating states.

Authors:  Natallia Makarava; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

3.  Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates.

Authors:  M P Morrissey; E I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Self-replication and scrapie.

Authors:  J S Griffith
Journal:  Nature       Date:  1967-09-02       Impact factor: 49.962

5.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

Authors:  K M Pan; M Baldwin; J Nguyen; M Gasset; A Serban; D Groth; I Mehlhorn; Z Huang; R J Fletterick; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit.

Authors:  Jon A Beck; Mark Poulter; Tracy A Campbell; Gary Adamson; James B Uphill; Rita Guerreiro; Graham S Jackson; James C Stevens; Hadi Manji; John Collinge; Simon Mead
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

7.  Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding.

Authors:  R Zahn; C von Schroetter; K Wüthrich
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

8.  Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.

Authors:  R M Whittal; H L Ball; F E Cohen; A L Burlingame; S B Prusiner; M A Baldwin
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

Review 9.  Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits.

Authors:  C Vital; F Gray; A Vital; P Parchi; S Capellari; R B Petersen; X Ferrer; D Jarnier; J Julien; P Gambetti
Journal:  Neuropathol Appl Neurobiol       Date:  1998-04       Impact factor: 8.090

10.  Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity.

Authors:  Young Jin Lee; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

View more
  1 in total

Review 1.  Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications.

Authors:  Niccolò Candelise; Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Roberta Misasi
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.